Literature DB >> 32800086

Opioid Misuse and the Availability of Medical Marijuana Through Dispensaries.

Bridget Freisthler1, Natalie Sumetsky2, Christiana Kranich1, Caileigh Chadwick1, Christina Mair2.   

Abstract

OBJECTIVE: In this study we assess whether changes in ZIP code-level density of medical marijuana facilities are related to changes in rates of opioid poisonings and opioid use disorder hospitalizations in California.
METHOD: A panel study using California hospital discharge data was conducted to assess the relationship between density of medical marijuana dispensaries and opioid poisonings and use disorder. There were 8,536 space-time units at the ZIP code level. Outcome measures included ZIP code counts of opioid poisonings and opioid use disorder; independent variables were local- and adjacent-area medical marijuana dispensaries and demographic and economic characteristics.
RESULTS: Independent of effects for covariates, densities of medical marijuana dispensaries were positively related to opioid use disorder (RR = 1.05, CI [1.03, 1.06]) and opioid poisonings (RR = 1.04, CI [1.02, 1.05]) in local areas, but negatively related to opioid misuse in spatially adjacent areas (RR = 0.91, CI [0.88, 0.94] for opioid use disorder, RR = 0.89, CI [0.86, 0.93] for opioid poisonings).
CONCLUSIONS: Although state-level studies suggest that more liberal marijuana policies may result in fewer opioid overdose deaths, our results within one state suggest that local availability of medical marijuana may not reduce those deaths. The relationship appears to be more complex, possibly based on socioeconomic conditions within and adjacent to areas with higher densities of medical marijuana dispensaries.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32800086      PMCID: PMC7437552     

Source DB:  PubMed          Journal:  J Stud Alcohol Drugs        ISSN: 1937-1888            Impact factor:   2.582


  40 in total

1.  Contribution of Opioid-Involved Poisoning to the Change in Life Expectancy in the United States, 2000-2015.

Authors:  Deborah Dowell; Elizabeth Arias; Kenneth Kochanek; Robert Anderson; Gery P Guy; Jan L Losby; Grant Baldwin
Journal:  JAMA       Date:  2017-09-19       Impact factor: 56.272

2.  Population-Level Analyses Cannot Tell Us Anything About Individual-Level Marijuana-Opioid Substitution.

Authors:  Theodore L Caputi; Kevin A Sabet
Journal:  Am J Public Health       Date:  2018-03       Impact factor: 9.308

3.  Medical Marijuana Users are More Likely to Use Prescription Drugs Medically and Nonmedically.

Authors:  Theodore L Caputi; Keith Humphreys
Journal:  J Addict Med       Date:  2018 Jul/Aug       Impact factor: 3.702

4.  Cannabis for therapeutic purposes: patient characteristics, access, and reasons for use.

Authors:  Zach Walsh; Robert Callaway; Lynne Belle-Isle; Rielle Capler; Robert Kay; Philippe Lucas; Susan Holtzman
Journal:  Int J Drug Policy       Date:  2013-09-09

5.  Fentanyl Law Enforcement Submissions and Increases in Synthetic Opioid-Involved Overdose Deaths - 27 States, 2013-2014.

Authors:  R Matthew Gladden; Pedro Martinez; Puja Seth
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-08-26       Impact factor: 17.586

6.  Characteristics of patients with chronic pain accessing treatment with medical cannabis in Washington State.

Authors:  Sunil K Aggarwal; Gregory T Carter; Mark D Sullivan; Craig ZumBrunnen; Richard Morrill; Jonathan D Mayer
Journal:  J Opioid Manag       Date:  2009 Sep-Oct

7.  Association of Medical and Adult-Use Marijuana Laws With Opioid Prescribing for Medicaid Enrollees.

Authors:  Hefei Wen; Jason M Hockenberry
Journal:  JAMA Intern Med       Date:  2018-05-01       Impact factor: 21.873

8.  Prescribing cannabis for harm reduction.

Authors:  Mark Collen
Journal:  Harm Reduct J       Date:  2012-01-01

9.  Vital Signs: Changes in Opioid Prescribing in the United States, 2006-2015.

Authors:  Gery P Guy; Kun Zhang; Michele K Bohm; Jan Losby; Brian Lewis; Randall Young; Louise B Murphy; Deborah Dowell
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-07-07       Impact factor: 17.586

Review 10.  Cannabis and Pain: A Clinical Review.

Authors:  Kevin P Hill; Matthew D Palastro; Brian Johnson; Joseph W Ditre
Journal:  Cannabis Cannabinoid Res       Date:  2017-05-01
View more
  1 in total

1.  Association between fatal opioid overdose and state medical cannabis laws in US national survey data, 2000-2011.

Authors:  June H Kim; Silvia S Martins; Dvora Shmulewitz; Deborah Hasin
Journal:  Int J Drug Policy       Date:  2021-09-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.